Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults
Status:
Terminated
Trial end date:
2017-06-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether the combination of BMS-955176 with
atazanavir (ATV) [with or without ritonavir (RTV)] and dolutegravir (DTG) is efficacious,
safe, and well-tolerated in HIV-1 infected treatment experienced adults.